Joseph DiBrino

524 total citations
6 papers, 128 citations indexed

About

Joseph DiBrino is a scholar working on Pharmacology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Joseph DiBrino has authored 6 papers receiving a total of 128 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 3 papers in Molecular Biology and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in Joseph DiBrino's work include Cannabis and Cannabinoid Research (2 papers), Neurotransmitter Receptor Influence on Behavior (2 papers) and Cancer therapeutics and mechanisms (1 paper). Joseph DiBrino is often cited by papers focused on Cannabis and Cannabinoid Research (2 papers), Neurotransmitter Receptor Influence on Behavior (2 papers) and Cancer therapeutics and mechanisms (1 paper). Joseph DiBrino collaborates with scholars based in United States. Joseph DiBrino's co-authors include James R. Hauske, David A. Griffith, Margaret S. Landis, Philip A. Iredale, Dennis O. Scott, Philip A. Carpino, Rebecca E. O’Connor, Paul DaSilva‐Jardine, Robert L. Dow and John R. Hadcock and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and Tetrahedron.

In The Last Decade

Joseph DiBrino

6 papers receiving 123 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph DiBrino United States 6 58 56 47 35 13 6 128
Zhengming Du United States 6 91 1.6× 93 1.7× 82 1.7× 21 0.6× 16 1.2× 10 246
Bandarpalle B. Shankar United States 7 50 0.9× 37 0.7× 80 1.7× 17 0.5× 25 1.9× 10 146
José Manuel Bartolomé-Nebreda Belgium 8 130 2.2× 29 0.5× 84 1.8× 71 2.0× 9 0.7× 16 218
Christopher W. Plummer United States 7 61 1.1× 41 0.7× 118 2.5× 26 0.7× 9 0.7× 10 240
Pamela A. Chambers United States 10 149 2.6× 46 0.8× 113 2.4× 80 2.3× 16 1.2× 16 336
F. F. Stephens United Kingdom 6 97 1.7× 25 0.4× 60 1.3× 63 1.8× 27 2.1× 13 261
Brian C. Magliaro United States 7 76 1.3× 21 0.4× 27 0.6× 42 1.2× 10 0.8× 10 187
Ling Shen China 7 157 2.7× 49 0.9× 17 0.4× 59 1.7× 11 0.8× 10 232
Bradley R. Teegarden United States 9 162 2.8× 35 0.6× 171 3.6× 41 1.2× 11 0.8× 11 348
Hans Stange Germany 8 126 2.2× 45 0.8× 56 1.2× 26 0.7× 7 0.5× 31 211

Countries citing papers authored by Joseph DiBrino

Since Specialization
Citations

This map shows the geographic impact of Joseph DiBrino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph DiBrino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph DiBrino more than expected).

Fields of papers citing papers by Joseph DiBrino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph DiBrino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph DiBrino. The network helps show where Joseph DiBrino may publish in the future.

Co-authorship network of co-authors of Joseph DiBrino

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph DiBrino. A scholar is included among the top collaborators of Joseph DiBrino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph DiBrino. Joseph DiBrino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Griffith, David A., John R. Hadcock, Shawn C. Black, et al.. (2008). Discovery of 1-[9-(4-Chlorophenyl)-8-(2-chlorophenyl)-9H-purin-6-yl]-4-ethylaminopiperidine-4-carboxylic Acid Amide Hydrochloride (CP-945,598), a Novel, Potent, and Selective Cannabinoid Type 1 Receptor Antagonist. Journal of Medicinal Chemistry. 52(2). 234–237. 55 indexed citations
2.
Brandt, Thomas A., Stéphane Caron, David B. Damon, et al.. (2008). Development of two synthetic routes to CE-178,253, a CB1 antagonist for the treatment of obesity. Tetrahedron. 65(16). 3292–3304. 20 indexed citations
3.
Reiter, Lawrence A., Kevin M. Koch, Anthony D. Piscopio, et al.. (1998). trans-3-Benzyl-4-hydroxy-7-chromanylbenzoic acid derivatives as antagonists of the leukotriene B4 (LTB4) receptor. Bioorganic & Medicinal Chemistry Letters. 8(14). 1781–1786. 11 indexed citations
4.
Hauske, James R., et al.. (1992). Design and synthesis of novel FKBP inhibitors. Journal of Medicinal Chemistry. 35(23). 4284–4296. 24 indexed citations
5.
Hauske, James R., et al.. (1986). Structure elucidation of a new neutral macrolide antibiotic. The Journal of Organic Chemistry. 51(14). 2808–2814. 11 indexed citations
6.
Nagel, A., Joseph DiBrino, Lawrence A. Vincent, & James A. Retsema. (1982). Ring contraction of oleandrose on the macrolide antibiotic oleandomycin with [(methoxycarbonyl)sulfamoyl]triethylammonium hydroxide inner salt. Journal of Medicinal Chemistry. 25(7). 881–884. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026